Equity Issuances

Madison Air Solutions Corp issued 3,703,704 shares of common stock to Madison Industries Holdings LLC (Holdings) for at a price per share equal to the IPO Price.

“the Company sold 3,703,704 shares of Class B Common Stock at a price per share equal to the IPO Price to Holdings in a concurrent private placement.”

Madison Air Solutions Corp issued 320,676,155 shares of common stock to Madison Industries Holdings LLC (Holdings) for in exchange for all of the issued and outstanding shares of capital stock of MIAQ Solutions.

“on April 15, 2026, the Company sold 320,676,155 shares of the Company’s Class B common stock, par value $0.0000001 per share (the “Class B Common Stock”), to Holdings in exchange for all of the issued and outstanding shares of capital stock of MIAQ Solutions.”

Madison Air Solutions Corp issued common stock to Kedge, certain unaffiliated institutional investors, certain unaffiliated investors, and certain executive officers, employees, and consultants for in exchange for LLC units of certain subsidiaries of the Company.

“On April 15, 2026, the Company sold (i) an aggregate of 44,841,071 shares of Class A Common Stock to Kedge, (ii) an aggregate of 14,311,991 shares of Class A Common Stock to certain unaffiliated institutional investors, (iii) an aggregate of 12,299,462 shares of Class A Common Stock to certain unaffiliated investors and (iv) an aggregate of 10,339,435 shares of Class A Common Stock to certain of the Company’s executive officers, including Jill Wyant, JJ Foley and Jeffrey Krautkramer, and certain other current employees and consultants of the Company, in each case in exchange for LLC units of certain subsidiaries of the Company.”

Soluna Holdings, Inc issued up to 2,400,000 shares of warrant to YA II PN, LTD. for $1.06 per share.

“provided by Section 4(a)(2) of the Securities Act promulgated thereunder and in reliance on similar exemptions under applicable state laws. The Warrant has an exercise price of $1.06 per share of Common Stock, is exercisable upon issuance and expires on the twelve-month anniversary of its date of issuance. The Warrant is exercisable, at the option of the”

Vaxart, Inc. issued 447,067 shares of Common Stock (the "Commitment Shares") of common stock to Lincoln Park Capital Fund, LLC for Lincoln Park committed to purchase up to $25.0 million of the Company’s common stock.

“rights agreement (the “ Registration Rights Agreement ”), with Lincoln Park Capital Fund, LLC (“ Lincoln Park ”), pursuant to which Lincoln Park committed to purchase up to $25.0 million of the Company’s common stock, par value $0.0001 per share (the “ Common Stock ”), subject to certain limitations and satisfaction of the conditions set forth in the Purchase”

VISIUM TECHNOLOGIES, INC. issued 1,597,868 shares of preferred stock to approximately forty (40) accredited investors and related parties (including certain officers) for full cancellation and satisfaction of $1,597,868.39 of outstanding indebtedness.

“On April 14, 2026, Visium Technologies, Inc. (the “Company”) issued an aggregate of 1,597,868 shares of its newly designated Series D Callable Convertible Preferred Stock (the “Series D Preferred Stock”) to approximately forty (40) accredited investors and related parties (including certain officers) in exchange for the full cancellation and satisfaction of $1,597,868.39 of outstanding indebtedness.”

VISIUM TECHNOLOGIES, INC. issued Four shares of preferred stock to certain accredited investors who are existing Series AA Preferred Stock holders and/or affiliates of the Company for aggregate nominal consideration.

“On April 14, 2026, the Company issued Four shares of its Series G Governing Preferred Stock, par value $0.001 per share, to certain accredited investors who are existing Series AA Preferred Stock holders and/or affiliates of the Company, for aggregate nominal consideration.”

VISIUM TECHNOLOGIES, INC. issued preferred stock to accredited investors for $750.00 per share.

“of Regulation D. No general solicitation or advertising was used. Material Terms of the Series E Convertible Preferred Stock (as set forth in the Series E CoD): · Stated Value : $750.00 per share. · Conversion Price : Fixed at $0.05 per share of common stock (par value $0.0001). Each share of Series E Preferred Stock is convertible into exactly 15,000 shares of”

XMax Inc. issued 462,500 shares of common stock to twenty two non-U.S. person investors, namely Chen Yingjie, Fang Chongyi, Jiang Yan, Ma Ying, Ren Guangfei, Ren Tao, Shen Xiaoyan, Song Rongrong, Tan Kaichang, Tang Min, Wang Haifeng, Wang Jinhua, Wang Li, Wang Zecui, Wei Huifen, Yao Jing, Yu Suying, Zeng Qingyu, Zhang Bingli, Zhang Ciqiang, Zhao Xia for $3,101,062.50.

“On April 13, 2026, XMax Inc. (the “ Company ”) entered into Securities Purchase Agreements (the “ Agreements ”) with twenty two non-U.S. person investors, namely Chen Yingjie, Fang Chongyi, Jiang Yan, Ma Ying, Ren Guangfei, Ren Tao, Shen Xiaoyan, Song Rongrong, Tan Kaichang, Tang Min, Wang Haifeng, Wang Jinhua, Wang Li, Wang Zecui, Wei Huifen, Yao Jing, Yu Suying, Zeng Qingyu, Zhang Bingli, Zhang Ciqiang, Zhao Xianxian and Zhao Zheyao (the “ Purchasers ”), pursuant to which the Company agreed to sell to the Purchasers in a private placement for a total of 462,500 shares (the “ Shares ”) of the Company’s common stock, par value $0.001 per share (the “ Common Stock ”), at a purchase price of $6.705 per share for an aggregate offering price of $3,101,062.50 (the “ Private Placement ”).”

Cottonwood Communities, Inc. issued 188,601 shares of preferred stock to accredited investors for aggregate proceeds of $1,849,005.

“Sales of Series A Convertible Stock During the period from April 1, 2026 through April 15, 2026, we issued and sold 188,601 shares of Series A Convertible Preferred Stock in the Series A Convertible Private Offering and received aggregate proceeds of $1,849,005.”

Momentus Inc. issued warrants to purchase 66,666 shares of Common Stock of warrant to Placement Agent for exercise price of $4.125 per share.

“issued to the Placement Agent warrants to purchase 66,666 shares of Common Stock (the “Placement Agent Warrants") at an exercise price of $4.125 per share”

Momentus Inc. issued pre-funded warrants to purchase up to 883,334 shares of Common Stock of warrant to an institutional investor for $3.75 per share minus the $0.00001 exercise price per share.

““Securities Purchase Agreement”) with an institutional investor (the “Investor”) for a private placement of (i) 450,000 shares of the Company’s Class A common stock, par value $0.00001 per share (the “Common Stock”), for $3.75 per share and (ii) pre-funded warrants to purchase up to 883,334 shares of Common Stock (the “Pre-Funded Warrants” and, together with”

Momentus Inc. issued 450,000 shares of common stock to an institutional investor for $3.75 per share.

“entered into a Securities Purchase Agreement (the “Securities Purchase Agreement") with an institutional investor (the “Investor") for a private placement of (i) 450,000 shares of the Company’s Class A common stock, par value $0.00001 per share (the “Common Stock"), for $3.75 per share”

INTERNATIONAL BATTERY METALS LTD. issued one warrant (each, a "Warrant") to purchase one common share of warrant to EV Metals VII LLC.

“Each Unit will include one Company common share and one warrant (each, a "Warrant") to purchase one common share and will be priced at USD $0.08 per Unit”

INTERNATIONAL BATTERY METALS LTD. issued Units of unit to EV Metals VII LLC for USD $0.08 per Unit, for total gross proceeds of USD $2.8 million.

“of the Company controlled by a director of the Company, Jacob Warnock. Under the terms of the LOI, affiliates of EV Metals have agreed to subscribe to purchase the remaining USD $2.8 million (the "Offering") of units ("Units") under the LOI. Each Unit will include one Company common share and one warrant (each, a "Warrant") to purchase one common share and will be”

Onfolio Holdings, Inc issued 50,000 shares of Common Stock of common stock to institutional investor.

“In connection with the Purchase Agreement, on the date of the Purchase Agreement, the Company issued the Commitment Shares to the Investor without registering the securities under the Securities Act, in reliance on the exemption from the registration requirements pursuant to Section 4(a)(2) of the Securities Act.”

ACHIEVE LIFE SCIENCES, INC. issued 49,418,069 shares of common stock to institutional and accredited investors for $3.635 per combination of Shares and accompanying Common Warrants.

“aggregate of (i) 49,418,069 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (“Common Stock"), and, in lieu of Shares for an Investor, pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 100,500 shares of Common Stock (the “Pre-Funded Warrant Shares”), and (ii) accompanying warrants (the “Common Warrants”) to purchase up to 49,518,569 shares of Common Stock or pre-funded warrants to purchase Common Stock (the “Common Warrant Shares,” and together with the Shares, Pre-Funded Warrant Shares, Pre-Funded Warrants and the Common Warrants, the “Securities”) at a collective purchase price of (a) $3.635 per combination of Shares and accompanying Common Warrants”

Traws Pharma, Inc. issued 5,982,919 shares of common stock to Institutional and accredited investors for $1.6730 per share for each Purchased Share and accompanying Series A, B, and C Warrants ($1.6630 for Pre-Funded Warrant).

“a Phase 2a human challenge trial in the United Kingdom. The purchase price per each Purchased Share and accompanying Series A Warrant, Series B Warrant, and Series C Warrant was $1.6730. The purchase price per each Pre-Funded Warrant and accompanying Series A Warrant, Series B Warrant, and Series C Warrant was $1.6630, and each Pre-Funded Warrant has an exercise”

FreeCast, Inc. issued an aggregate of 6,743,587 shares of our Class A common stock of warrant to 137 accredited investors for $4.25 per share.

“us on April 10, 2026, to the same holders of the 137 warrants to purchase the same aggregate number of shares that expired on December 31, 2025. The exercise price per share is $4.25, which is the closing price of a share of our Class A common stock on the Nasdaq Global Market on April 1, 2026, and may only be paid for with cash. There is no cashless exercise”

CoreWeave, Inc. issued 9,174,311 shares of common stock to Jane Street Global Trading, LLC for $109.00 per share for an aggregate purchase price of approximately $1.0 billion.

“On April 15, 2026, the Company completed the issuance and sale of 9,174,311 shares of the Company’s Class A common stock, par value $0.000005 per share (the “Shares”), pursuant to the Purchase Agreement, at a price of $109.00 per share for an aggregate purchase price of approximately $1.0 billion in cash.”

Zapata Quantum, Inc. issued Warrants to purchase a total of 4,270,098 shares of the Company’s common stock of warrant to accredited investors for part of the same offering for gross proceeds of $3,750,000.

“On April 9, 2026 and April 14, 2026, Zapata Quantum, Inc. (the “Company”) sold and issued to accredited investors a total of 3,750 shares of Series D Convertible Preferred Stock (the “Series D”), together with Warrants (the “Warrants”) to purchase a total of 4,270,098 shares of the Company’s common stock, for gross proceeds of $3,750,000”

Zapata Quantum, Inc. issued 3,750 shares of Series D Convertible Preferred Stock of preferred stock to accredited investors for gross proceeds of $3,750,000.

“On April 9, 2026 and April 14, 2026, Zapata Quantum, Inc. (the “Company”) sold and issued to accredited investors a total of 3,750 shares of Series D Convertible Preferred Stock (the “Series D”), together with Warrants (the “Warrants”) to purchase a total of 4,270,098 shares of the Company’s common stock, for gross proceeds of $3,750,000”

SUNation Energy, Inc. issued common stock to Scott Maskin and James Brennan for conversion of up to $1,200,000 of debt.

“On April 14, 2026, the Board of Directors approved entry into a “Debt Conversion Agreement” in connection with the conversion of up to $1,200,000 of debt payable under the Long-Term Note into shares of restricted common stock (the “Conversion Shares”) of the Company pursuant to Regulation D of the Securities Act of 1933, as amended, on the following terms: (1) the Conversion Shares shall consist of restricted shares of voting common stock, par value $.05 per share, (2) the Conversion Shares shall be issued at a price per share of $1.77”

GRAHAM CORP issued 599,808 shares of common stock to accounts advised by T. Rowe Price Investment Management, Inc. for $83.36 per share for aggregate gross proceeds of $50 million.

“On April 14, 2026, Graham Corporation (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accounts advised by T. Rowe Price Investment Management, Inc. (the “Investors”) pursuant to which the Company agreed to sell an aggregate of 599,808 shares of its common stock, par value $0.10 per share (the “Shares”) for $83.36 per share for aggregate gross proceeds of $50 million (the “PIPE”).”

Mitesco, Inc. issued 2,922,915 shares of common stock to accredited investors for $201,400.

“The Company issued a total of 2,922,915 shares in redemption of $201,400 of its Series A Preferred Stock for Q1.”

Mitesco, Inc. issued 222,142 shares of restricted common stock of common stock to accredited Institutional investors.

“The Company will issue a total of 222,142 shares of restricted common stock for the payment of its dividends on its Series X Preferred shares for Q1 FY2026.”

Mitesco, Inc. issued convertible note to Jefferson Street Capital, LLC. and Pinz Special Opportunities Fund, LP for $50,000 purchase price.

“received funding from two (2) historical investors in the Company from new 2026 Bridge Notes. The 10% Original Issue Discount Convertible Promissory Notes (the “2026 Bridge Note”) with Jefferson Street Capital, LLC. and with Pinz Special Opportunities Fund, LP, have a $50,000 purchase price.”

New Concept Energy, Inc. issued up to 2,000,000 shares of Common Stock of common stock.

“Item 3.02. Unregistered Sales of Equity Securities See Item 1.01 above for a description of an agreement covering the proposed issuance of up to 2,000,000 shares of Common Stock of the Company without registration, based upon the exemption afforded by Section 4(2) of the Securities Act of 1933, as amended.”

Worksport Ltd issued 88,214 shares of common stock to Steven Rossi for $0.8502 per share.

“On April 13, 2026, Worksport Ltd. (the “Company”) issued to its Chief Executive Officer, Steven Rossi, 88,214 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a deemed price of $0.8502 per share, representing the closing price of the Company’s Common Stock on the Nasdaq Capital Market on April 10, 2026, for an aggregate value of $75,000.”

OneMeta Inc. issued up to 22,222,222 shares of common stock of warrant to Avaya LLC.

“On April 9, 2026, OneMeta Inc. (the “Company”) issued a warrant (the “Warrant”) to Avaya LLC (“Avaya”) to purchase up to 22,222,222 shares of common stock of the Company at an exercise price of $0.135 per share (the “Exercise Price”)”

Glucotrack, Inc. issued 895,000 shares of common stock.

“Under the Exchange Agreement, the Company and the Investor further agreed to exchange the Partitioned Note for an aggregate of 895,000 shares of the Company’s common stock, no par value per share (the “Exchange Shares”).”

CareCloud, Inc. issued 4,300,000 shares of common stock of warrant to Mahmud Haq for pledge of certain securities accounts as additional collateral support for the Credit Facility.

“Mahmud Haq, the Company’s Executive Chairman, will enter into a Securities Account Pledge Agreement in favor of Citizens, as administrative agent, pursuant to which he will pledge certain securities accounts as additional collateral support for the Credit Facility. In consideration for this pledge, Mr. Haq will receive a warrant exercisable for 4,300,000 shares of common stock of the Company at a strike price of $5.00 per share (the “Warrant”).”

Commerce.com, Inc. issued securities.

“On April 13, 2026, Commerce.com, Inc. (the “ Company ”) entered into a Rights Agreement between the Company and Equiniti Trust Company, LLC as Rights Agent (as amended from time to time, the “ Rights Agreement ”) that was previously approved by the Board of Directors of the Company.”

CaliberCos Inc. issued 1,529 shares of Series AAA Preferred Stock of preferred stock to Note Holders for $1,528,500 of outstanding Notes cancelled.

“As of April 9, 2026, the Company has entered into subscription agreements with the Note Holders whereby the Note Holders converted and cancelled an aggregate of $3,450,271 of outstanding indebtedness of the Company, consisting of $1,921,771 of outstanding Notes in exchange for 1,707,900 shares of Class A Common Stock and $1,528,500 of outstanding Notes in exchange for 1,529 shares of Series AAA Preferred Stock.”

CaliberCos Inc. issued 1,707,900 shares of Class A Common Stock of common stock to Note Holders for $1,921,771 of outstanding Notes cancelled.

“As of April 9, 2026, the Company has entered into subscription agreements with the Note Holders whereby the Note Holders converted and cancelled an aggregate of $3,450,271 of outstanding indebtedness of the Company, consisting of $1,921,771 of outstanding Notes in exchange for 1,707,900 shares of Class A Common Stock and $1,528,500 of outstanding Notes in exchange for 1,529 shares of Series AAA Preferred Stock.”

urban-gro, Inc. issued 26,000 shares of Common Stock of warrant to Agile Hudson Partners LLC.

“In connection with the funding of the First Tranche, the Company issued to the Buyer (i) a Common Stock purchase warrant to purchase up to 154,166 shares of Common Stock at an initial exercise price of $18.00 per share (the “First Warrant”) and (ii) a pre-funded Common Stock purchase warrant to purchase up to 26,000 shares of Common Stock at an initial exercise price of $0.01 per share (the “Second Warrant,” and together with the First Warrant, the “Warrants”).”

urban-gro, Inc. issued 154,166 shares of Common Stock of warrant to Agile Hudson Partners LLC.

“In connection with the funding of the First Tranche, the Company issued to the Buyer (i) a Common Stock purchase warrant to purchase up to 154,166 shares of Common Stock at an initial exercise price of $18.00 per share (the “First Warrant”) and (ii) a pre-funded Common Stock purchase warrant to purchase up to 26,000 shares of Common Stock at an initial exercise price of $0.01 per share (the “Second Warrant,” and together with the First Warrant, the “Warrants”).”

urban-gro, Inc. issued convertible note to Agile Hudson Partners LLC for $2,025,000.

“Pursuant to the Purchase Agreement, the Buyer funded the first tranche in the original principal amount of $2,225,495.05 (the “First Tranche”) for a purchase price of $2,025,000 (the “Purchase Price”).”

Repay Holdings Corp issued preferred stock.

“On April 13, 2026, the Board of Directors (the “Board”) of Repay Holdings Corporation (the “Company”) declared a dividend of one preferred share purchase right (a “Right”) for each outstanding share of Class A common stock”

CoreWeave, Inc. issued convertible note to qualified institutional buyers for $4,000,000,000 aggregate principal amount.

“On April 14, 2026, CoreWeave completed its previously announced private offering of $4,000,000,000 aggregate principal amount of its 1.75% Convertible Senior Notes due 2032”

Vireo Growth Inc. issued 80,000,000 subordinate voting shares of warrant to Good Dog Holdings LLC, as the Seller's designee for exercise price of $0.85.

“Additionally, pursuant to the SPA, the Company executed and delivered to the Seller Designee a warrant agreement (the “Warrant Agreement”) to purchase 80,000,000 subordinate voting shares at an exercise price of $0.85 (the “Warrants”).”

Vireo Growth Inc. issued 213,000,000 subordinate voting shares of common stock to Good Dog Holdings LLC, as the Seller's designee for deemed value of $0.60 per share.

“Pursuant to the SPA, the Company issued to Good Dog Holdings LLC, as the Seller’s designee (the “Seller Designee”), 213,000,000 subordinate voting shares (the “Vireo Shares”) at a deemed value of $0.60 per share”

Aptera Motors Corp issued warrants to purchase up to 210,000 shares of Class B common stock of warrant to Zaptera USA, Inc..

“On April 8, 2026, the Company agreed to issue to Zaptera 105,000 shares of the Company’s Class B common stock, par value $0.0001 per share (the “ Shares ”), and warrants to purchase up to 210,000 shares of Class B common stock (the “ Warrants ”).”

Aptera Motors Corp issued 105,000 shares of the Company's Class B common stock of common stock to Zaptera USA, Inc. for consideration for the Settlement.

“On April 8, 2026, the Company agreed to issue to Zaptera 105,000 shares of the Company’s Class B common stock, par value $0.0001 per share (the “ Shares ”), and warrants to purchase up to 210,000 shares of Class B common stock (the “ Warrants ”).”

Lucid Group, Inc. issued preferred stock.

“The Convertible Preferred Stock will rank senior to the Common Stock with respect to dividends and distributions of assets upon the Company’s liquidation, dissolution or winding up.”

Lucid Group, Inc. issued 24,038,462 shares of common stock to SMB Holding Corporation for $200 million.

“in a private placement (the “ PIF Private Placement ”); and (ii) SMB Holding Corporation (“ SMB ”), a subsidiary of Uber Technologies, Inc. (“ Uber ”), has agreed to purchase $200 million of Lucid’s Class A common stock, par value $0.0001 per share (the “ Common Stock ”), in a private placement (the “ Uber Private Placement ”) in connection with the Second VPA (as”

Lucid Group, Inc. issued 55,000 shares of preferred stock to Ayar Third Investment Company for $550 million.

“”) announced that (i) Lucid’s majority stockholder, Ayar Third Investment Company (“ Ayar ”), an affiliate of the Public Investment Fund (“ PIF ”), has agreed to purchase $550 million of Lucid’s Series C Convertible Preferred Stock, par value $0.0001 per share (the “ Convertible Preferred Stock ”), in a private placement (the “ PIF Private Placement ”); and”

CERO THERAPEUTICS HOLDINGS, INC. issued convertible note to Keystone Capital Partners, LLC for purchase price of $350,000.

“On April 8, 2026, CERo Therapeutics Holdings, Inc., a Delaware corporation (the “Company”) issued and sold a convertible promissory note for an purchase price of $350,000, having a principal face value of $437,500 (the “Note”) to Keystone Capital Partners, LLC (“Lender”).”

Haymaker Acquisition Corp. 4 issued common stock.

“At the Shareholder Meeting, Haymaker's shareholders approved an Amended and Restated Certificate of Incorporation of the Company (the "Certificate of Incorporation") to replace the Company's current certificate of formation following the Business Combination.”

Haymaker Acquisition Corp. 4 issued 26,000 shares of Series A Preferred Stock of preferred stock to Senior Preferred Unit holders for in exchange for their Senior Preferred Units.

“On April 8, 2026, the Exchange occurred immediately prior to the closing of the Acquisition Merger, and the Company issued 26,000 shares of Series A Preferred Stock to the Senior Preferred Unit holders, following the acceptance by the Secretary of State of the State of Delaware of the Certificate of Designation.”